{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:41:12Z","timestamp":1785552072836,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cyto.2016.06.013","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T02:11:30Z","timestamp":1467339090000},"page":"184-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-\u03b3 production by spleen cells from human visceral leishmaniasis patients"],"prefix":"10.1016","volume":"85","author":[{"given":"Neetu","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Engwerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Nylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-582X","authenticated-orcid":false,"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.06.013_b0005","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2016.06.013_b0010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0015","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1128\/IAI.68.11.6289-6293.2000","article-title":"Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment","volume":"68","author":"Murray","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2016.06.013_b0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0167-5699(99)01573-X","article-title":"Tumor necrosis factor: a master-regulator of leukocyte movement","volume":"21","author":"Sedgwick","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cyto.2016.06.013_b0025","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","article-title":"TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection","volume":"168","author":"Roach","year":"2002","journal-title":"J. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.cyto.2016.06.013_b0030","doi-asserted-by":"crossref","first-page":"ii37","DOI":"10.1136\/ard.62.suppl_2.ii37","article-title":"Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF","volume":"62","author":"Ehlers","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2016.06.013_b0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ncprheum0336","article-title":"Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor","volume":"2","author":"Winthrop","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.cyto.2016.06.013_b0040","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.170.6.2097","article-title":"Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis","volume":"170","author":"Titus","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2016.06.013_b0045","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.166.6.4012","article-title":"Rapidly fatal leishmaniasis in resistant C57BL\/6 mice lacking TNF","volume":"166","author":"Wilhelm","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0050","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1128\/IAI.59.8.2839-2842.1991","article-title":"Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo","volume":"59","author":"Theodos","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2016.06.013_b0055","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4049\/jimmunol.157.2.827","article-title":"Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication","volume":"157","author":"Vieira","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0060","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.4049\/jimmunol.160.11.5506","article-title":"Control of Leishmania major infection in mice lacking TNF receptors","volume":"160","author":"Nashleanas","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.153.2.768","article-title":"Role and effect of TNF-alpha in experimental visceral leishmaniasis","volume":"153","author":"Tumang","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0070","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"Liew","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","article-title":"Interleukin-10 therapy \u2013 review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cyto.2016.06.013_b0080","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nylen","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2016.06.013_b0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(06)70577-1","article-title":"The two faces of interleukin 10 in human infectious diseases","volume":"6","author":"Mege","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cyto.2016.06.013_b0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/eji.1830270409","article-title":"Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation","volume":"27","author":"Vouldoukis","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0095","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0100","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1469-0691.2011.03674.x","article-title":"Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe","volume":"18","author":"Zanger","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cyto.2016.06.013_b0105","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3201\/eid1506.090101","article-title":"Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe","volume":"15","author":"Xynos","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cyto.2016.06.013_b0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijid.2014.12.036","article-title":"Mucosal relapse of visceral leishmaniasis in a child treated with anti-TNFalpha","volume":"33","author":"Jeziorski","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cyto.2016.06.013_b0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.semarthrit.2013.01.006","article-title":"Leishmaniasis during anti-tumor necrosis factor therapy: report of 4 cases and review of the literature (additional 28 cases)","volume":"43","author":"Guedes-Barbosa","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.cyto.2016.06.013_b0120","first-page":"503","article-title":"Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature","volume":"27","author":"De Leonardis","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cyto.2016.06.013_b0125","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cyto.2016.06.013_b0130","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s10067-006-0356-5","article-title":"Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept","volume":"26","author":"Bagalas","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cyto.2016.06.013_b0135","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000370238","article-title":"Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature","volume":"230","author":"Catala","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.cyto.2016.06.013_b0140","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/IAI.70.12.6919-6925.2002","article-title":"Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection","volume":"70","author":"Karplus","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2016.06.013_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1902s108","article-title":"Animal models for the analysis of immune responses to leishmaniasis","volume":"108","author":"Sacks","year":"2015","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0150","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/JCM.01733-09","article-title":"Evaluation of blood agar microtiter plates for culturing leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis","volume":"48","author":"Maurya","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cyto.2016.06.013_b0155","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jir461","article-title":"IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis","volume":"204","author":"Gautam","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2016.06.013_b0160","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.1003588","article-title":"IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis","volume":"186","author":"Ansari","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0165","doi-asserted-by":"crossref","first-page":"e3198","DOI":"10.1371\/journal.pntd.0003198","article-title":"Leishmania specific CD4 T cells release IFNgamma that limits parasite replication in patients with visceral leishmaniasis","volume":"8","author":"Kumar","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cyto.2016.06.013_b0170","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/CVI.00143-12","article-title":"Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood","volume":"19","author":"Singh","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0175","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)63262-2","article-title":"Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection","volume":"165","author":"Engwerda","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2016.06.013_b0180","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.06.013_b0185","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/IAI.68.3.1428-1434.2000","article-title":"Activated T cells induce macrophages to produce NO and control Leishmania major in the absence of tumor necrosis factor receptor p55","volume":"68","author":"Nashleanas","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2016.06.013_b0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cyto.2016.06.013_b0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2334-12-75","article-title":"Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection","volume":"12","author":"Giudice","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cyto.2016.06.013_b0200","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/IAI.59.5.1709-1715.1991","article-title":"Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli","volume":"59","author":"Wherry","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2016.06.013_b0205","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4049\/jimmunol.167.12.6821","article-title":"In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL","volume":"167","author":"Via","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0210","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI38482","article-title":"Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans","volume":"119","author":"Bruns","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.06.013_b0215","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2016.06.013_b0220","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.4049\/jimmunol.158.8.3813","article-title":"Destruction of follicular dendritic cells during chronic visceral leishmaniasis","volume":"158","author":"Smelt","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0225","first-page":"951","article-title":"Laboratory diagnosis of visceral leishmaniasis","volume":"9","author":"Sundar","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.cyto.2016.06.013_b0230","first-page":"192","article-title":"Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis","volume":"39","author":"Franklin","year":"2009","journal-title":"Ann. Clin. Lab. Sci."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616301417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616301417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T23:25:36Z","timestamp":1748993136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616301417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":46,"alternative-id":["S1043466616301417"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.06.013","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-\u03b3 production by spleen cells from human visceral leishmaniasis patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}